BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23381074)

  • 1. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.
    Chandra S; Agarwal D; Surana A
    Am J Gastroenterol; 2013 Feb; 108(2):277-8. PubMed ID: 23381074
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitor use may be associated with an increased risk of Clostridium difficile infection.
    Stevens V; van Wijngaarden E
    Evid Based Med; 2013 Oct; 18(5):193-4. PubMed ID: 23220471
    [No Abstract]   [Full Text] [Related]  

  • 3. Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea?
    Freedberg DE; Abrams JA
    Am J Gastroenterol; 2013 Feb; 108(2):278-9. PubMed ID: 23381076
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Chandra et al., and Freedberg and Abrams.
    Loke YK; Kwok CS
    Am J Gastroenterol; 2013 Feb; 108(2):279-80. PubMed ID: 23381077
    [No Abstract]   [Full Text] [Related]  

  • 5. How much do PPIs contribute to C. difficile infections?
    Leontiadis GI; Miller MA; Howden CW
    Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.
    Leffler D; Cloud JW; Kelly CP
    JAMA; 2006 Jun; 295(22):2599-600; author reply 2600-1. PubMed ID: 16772617
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
    Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
    Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does stress ulcer prophylaxis explain the association between clostridium difficile-associated disease and mechanical ventilation?
    Porath AD
    Chest; 2010 Apr; 137(4):1001; author reply 1001-2. PubMed ID: 20371539
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and the risk for Clostridium difficile infection.
    Famularo G; Gasbarrone L; De Simone C
    JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
    JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection: managing the risks.
    DeDea L
    JAAPA; 2012 May; 25(5):16. PubMed ID: 22712142
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.
    Mizui T; Teramachi H; Tachi T; Tamura K; Shiga H; Komada N; Umeda M; Koda A; Aoyama S; Goto C; Tsuchiya T
    Pharmazie; 2013 Aug; 68(8):706-10. PubMed ID: 24020129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
    Hauben M; Horn S; Reich L; Younus M
    Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of proton pump inhibitor types for Clostridium difficile infection.
    Kim YG; Jang BI
    J Clin Gastroenterol; 2013 Mar; 47(3):292. PubMed ID: 23391870
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of proton pump inhibitor types for Clostridium difficile infection.
    Alagozlu H; Karakan T
    J Clin Gastroenterol; 2013 Mar; 47(3):290. PubMed ID: 23164689
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
    Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
    J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?
    McCarthy DM
    J Clin Gastroenterol; 2012; 46(5):350-3. PubMed ID: 22495812
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.